Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Aastrom Biosciences (ASTM)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for ASTM as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
228K
VERY LOW
EBITDA
►
-15.1M
AVG
Net Income
►
-15.8M
AVG
Revenue Growth
►
-50.6%
LOW
Operating Margin
►
-6916.2%
LOW
Net Margin
►
-6944.7%
LOW
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.131
LOW
Current Ratio
►
9.00
HIGH
Quick Ratio
►
9.00
HIGH
Interest Coverage Ratio
►
-243
AVG
Book Value Per Share
►
0.0966
Cash Per Share
►
0.0941
Loading...
STOCK SUMMARY
Open
0.37
Day Range
0.27
-
0.37
52 Week Range
0.26
-
0.78
Volume
5.17M
Avg Volume (3 mo)
1.51M
Shares Outstanding
196M
Market Cap
62.5M
VALUATION
Price to Earnings (P/E)
►
-3.85
Price to Book (P/B)
►
3.42
AVG
Price to Sales (P/S)
►
267
HIGH
Return on Assets (ROA)
►
-74.2%
AVG
Return on Equity (ROE)
►
-84.2%
AVG
EV/EBITDA
►
-5.20
Dividend Yield
0%
AVG
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0%
Held by insiders
0.6%
Held by institutions
1.9%
No Sales Breakout Data.